CClinicalTrials.gg
CompletedNCT07315269Updated Jan 2, 2026

The Relationship Between Power Sleep and Sleep Quality, Depression, and Stress Levels in University Students

An interventional study of Daytime Power Napping in Sleep Quality, Depression Disorders and Stress, Psychological, sponsored by okkes zortuk. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-02.

Sponsored by okkes zortuk · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled Dec 2023, registered Dec 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This prospective cohort study aims to evaluate the effects of daily daytime power napping on sleep quality, depression, and perceived stress levels among healthy individuals. The study particularly investigates whether these effects differ between daytime workers and shift workers. Participants are required to practice a 15-20 minute (maximum 30 minutes) power nap daily for a period of six weeks. Changes in psychological and sleep parameters are assessed using the Jenkins Sleep Scale (JSS), Beck Depression Scale (BDS), and Perceived Stress Scale (PSS) before and after the intervention.

Read the detailed description

The study was conducted with 40 healthy volunteers (including 29 daytime workers and 11 shift workers) to analyze the impact of daytime napping on mental health and sleep hygiene.

Methodology: At the beginning of the study, participants' demographic information was collected, and baseline assessments were performed using the Jenkins Sleep Scale (JSS) for sleep patterns, the Beck Depression Scale (BDS) for depressive symptoms, and the Perceived Stress Scale (PSS) for stress levels.

Intervention: Participants were instructed to take a short nap (power nap) between 1:00 PM and 3:00 PM for daytime workers, or at suitable intervals for shift workers, every day for 6 weeks. The duration of the nap was strictly limited to 15-30 minutes to avoid sleep inertia.

Evaluation: After the 6-week intervention period, the same scales (JSS, BDS, and PSS) were administered as a post-test. The data were analyzed to compare the pre-test and post-test scores, with a focus on the differences in outcomes between different work schedules (shift vs. daytime). The study adheres to the principles of the Declaration of Helsinki and was approved by the Dicle University Social Sciences and Humanities Ethics Committee.

02

Conditions studied

  • Sleep Quality
  • Depression Disorders
  • Stress, Psychological
  • Occupational Stress

Keywords

  • Naps
  • Power napping
  • Shift workers
  • Daytime sleep
  • Mental health
  • Prospective cohort study
03

In context

Sleep Initiation and Maintenance Disorders

1,856 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 594 are open to participants now.

This study's enrollment of 40 is below the median of 73 across 1,631 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

This is the only study on the registry with okkes zortuk as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Being a healthy volunteer.
  • Being actively employed as either a daytime worker or a shift worker.
  • Providing written informed consent to participate in the study.
  • Willingness to adhere to a 6-week daytime power napping protocol.

Exclusion criteria

Exclusion Criteria:

  • Presence of diagnosed severe sleep disorders (e.g., severe insomnia or sleep apnea) that might interfere with the study protocol.
  • Inability to complete the 6-week power napping intervention.
  • Missing or incomplete psychological scale data at baseline or post-test.
  • Failure to perform the power nap as instructed during the study period.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Daytime Power Nap Group

    A group of 40 participants who are instructed to perform a 15-20 minute power nap daily for 6 weeks.

    Behavioral: Daytime Power Napping

Interventions

  • BehavioralDaytime Power Napping

    The duration, effectiveness, and method of intervention in this area should be clearly stated: Duration Per Session: Each nap is planned to be between 15-20 minutes, and limited to a maximum of 30 minutes to prevent sleepiness (sleep inertia). Total Duration: The intervention is a 6-week process. Target Group: 40 healthy volunteers (including day and shift workers). Goal: To enhance the privacy of sleep in daily life, reduce virus spread, and decrease stress.

06

What researchers measure

Primary outcomes

  1. Change in Sleep Quality as measured by the Jenkins Sleep Scale

    The JSS is a 4-item scale used to assess sleep problems, specifically focusing on difficulties falling asleep and maintaining sleep quality. Each item is scored on a 6-point Likert scale (0-20 total range). Higher scores indicate more sleep problems.

    Time frame: Baseline (Day 0) and at the end of the 6-week intervention period.

Secondary outcomes

  1. Change in Depressive Symptoms as measured by the Beck Depression Scale (BDS/BDI)

    The BDS consists of 21 questions designed to assess cognitive, somatic, and emotional symptoms of depression. Scores range from 0 to 63. Higher scores indicate more severe depressive symptoms.

    Time frame: Baseline (Day 0) and at the end of the 6-week intervention period.

  2. Change in Perceived Stress as measured by the Perceived Stress Scale (PSS).

    The 10-item version of the PSS measures an individual's perception of stress in their current situation. It includes two sub-dimensions: "perception of inadequate self-efficacy" and "perception of stress discomfort". Higher scores indicate a higher level of perceived stress.

    Time frame: Baseline (Day 0) and at the end of the 6-week intervention period.

07

Study locations

1 site
  • Dicle University
    Diyarbakır, Diyarbakar 21000, Turkey (Türkiye)
08

References and documents

Publications

  • Brown JP, Martin D, Nagaria Z, Verceles AC, Jobe SL, Wickwire EM. Mental Health Consequences of Shift Work: An Updated Review. Curr Psychiatry Rep. 2020 Jan 18;22(2):7. doi: 10.1007/s11920-020-1131-z. PubMed 31955278 ↗
  • Faraut B, Boudjeltia KZ, Dyzma M, Rousseau A, David E, Stenuit P, Franck T, Van Antwerpen P, Vanhaeverbeek M, Kerkhofs M. Benefits of napping and an extended duration of recovery sleep on alertness and immune cells after acute sleep restriction. Brain Behav Immun. 2011 Jan;25(1):16-24. doi: 10.1016/j.bbi.2010.08.001. Epub 2010 Aug 8. PubMed 20699115 ↗
  • Juhola J, Arokoski JPA, Ervasti J, Kivimaki M, Vahtera J, Myllyntausta S, Saltychev M. Internal consistency and factor structure of Jenkins Sleep Scale: cross-sectional cohort study among 80 000 adults. BMJ Open. 2021 Jan 18;11(1):e043276. doi: 10.1136/bmjopen-2020-043276. PubMed 33462100 ↗

Individual participant data

Plan to share: No — To maintain participant confidentiality and comply with the institutional ethics committee's guidelines, individual participant data (IPD) will not be made publicly available. However, metadata and study results are reported within the manuscript.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07315269
Lead sponsor
okkes zortuk
Responsible party
okkes zortuk (Manager, Ataturk University) — Sponsor-investigator
First posted
Jan 2, 2026
Start date
Dec 1, 2023
Primary completion
Jan 1, 2024
Completion
Dec 1, 2024
Last update
Jan 2, 2026

Study contacts

Ökkeş Zortuk
principal investigator · Emergency Medicine Department, Defne Government Hospital
Yeşim Dersuneli, MSc
study director · Clinical Psychology, Muş Alparslan University
Özlem Tolan, PHd
study chair · Clinical Psychology, Dicle University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion